Marlan Walker

Equibles does not estimate personal net worth.

About Marlan Walker

TherapeuticsMD, Inc. reported in an 8-K filed January 3, 2023 that Marlan Walker was appointed Principal Executive Officer, effective December 30, 2022. TherapeuticsMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at TherapeuticsMD, Inc. includes Brian Bernick (CEO), Mark Glickman (CEO), Marlan D. Walker (CEO and General Counsel) and 7 others.

“Mr. Marlan Walker, the Company's General Counsel, was appointed as the Company's Principal Executive Officer, succeeding Dr. Brian Bernick and Mr. Mark Glickman.”

TherapeuticsMD, Inc. Form 8-K, filed January 3, 2023 · Read the filing

Affiliation history

TherapeuticsMD, Inc. (TXMD)
SEC 8-K

Current
2022-12-30–present
TherapeuticsMD, Inc. (TXMD)
General Counsel

Proxy statement

Start not stated–2020-05-04

Last confirmed by a filing; no departure on record

Company network

TherapeuticsMD, Inc.

TXMD

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Leadership on record at TherapeuticsMD, Inc.

Brian Bernick CEO
Mark Glickman CEO
Marlan D. Walker CEO, General Counsel
Robert Finizio CEO, Board Member
Tommy G. Thompson Chairman, Board Member
Tommy Thompson Chairman
James C. D'Arecca CFO
Joseph Ziegler CFO
Adam Miller CIO
Cooper C. Collins Board Member

Recent activity

Executive change Appointed: Principal Executive Officer TherapeuticsMD, Inc. (TXMD)
2022-12-30